|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 366.20 USD | -0.10% |
|
-0.44% | +11.88% |
| 02-12 | Amgen Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-12-2026 05:00 PM | |
| 02-12 | European Commission approves Amgen's Uplizna® for generalized myasthenia gravis | RE |
MarketScreener Editorial Features
Search
No results for this search
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
































